Novencia Pharmasp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2008-05-16
Share capital
50,000.00 PLN
Registered address
Astronomów 3/206, 01-450 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Pascal Boury – Management Board Member
Daniel Krol – Management Board Member
Ewa Katarzyna Wojtowicz – President of the Management Board
Manner of representation
Each member of the management board acting independently is authorized to submit declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Daniel Krol | 250 | $3,376.55 | 25% |
Laboratories Envencia Sp. z o.o. | 500 | $6,753.11 | 50% |
Ewa Katarzyna Wojtowiczage 60 | 200 | $2,701.24 | 20% |
Others | 50 | $675.31 | 5% |
Beneficial owners
No beneficial owners recorded for the company Novencia Pharma.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-11 | Business resumed | |
| 2014-10-01 | Business suspended | |
| 2009-12-23 | Address change (Aleje Jerozolimskie 49/9a, 00-697, Warszawa → Astronomów 3/206, 01-450, Warszawa) | |
| 2008-05-16 | Entered in the register |
FAQ
Last updated: 2026-04-15